Review · partner · checked August 2026
$249/mo
Month to month, no prepay. Read off their site August 2026.
$249 a month for sublingual semaglutide, $297 for injections, with no membership and no minimum term — the cleanest pricing structure in this roster.
Direct Meds is more expensive than most of this roster and easier to understand than all of it. One monthly rate, everything in it, cancel when you want.
The pricing page does what we wish every page did: prints the number, states the term, and does not make you find the asterisk.
| Plan | Per month | Charged today |
|---|---|---|
| Month to month, sublingual | $249 | $249 |
| Plan | Per month | Charged today |
|---|---|---|
| Month to month, injection · advertised | $297 | $297 |
| Plan | Per month | Charged today |
|---|---|---|
| Month to month, injection | $399 | $399 |
$297 a month for compounded semaglutide injections, $399 for tirzepatide, $249 for sublingual semaglutide. The rate covers the medication, nurse support, shipping and digital follow-ups.
No membership and no minimum term: the site's own badges read No Monthly Memberships and Cancel Anytime. Bulk pricing for six and twelve month plans is mentioned without numbers, and the multi-month options on the product page do not render a price we could read.
The refund terms sit under the terms page rather than a standalone policy, and the homepage promises a full refund if a doctor decides treatment is not a good option.
The full breakdown — what is included, what is extra, and what happens at higher doses — is on the Direct Meds cost page.
Anyone shopping on headline price. At $297 for injections this is roughly three times CoreAge and it will lose that comparison every time.
Anyone who wants a named pharmacy or FDA-approved brand medication; you get neither.
Anyone who wants the terms in one place. The refund language sits inside the terms page rather than a policy of its own, and the multi-month options do not render a price on the product page.
| Prescriber licensed in your state | Not stated |
| Pharmacy named | Not named |
| What you get | Compounded semaglutide (injection and sublingual) and tirzepatide; no FDA-approved brand |
| Overseas fulfillment | None disclosed |
| Support hours | Phone 888-696-7176; no hours published |
These are the checks this site applies to every company — how we review. Not stated means we could not find it on their site, which is a finding about the site, not about the company.
Direct Meds carries an FDA warning letter, number 716822, issued September 2025 and published in FDA's warning-letter index, concerning the online sale and labeling of compounded semaglutide and tirzepatide. No FDA action has halted the business and it continues to operate. Most warning letters concern marketing and labeling claims rather than a finding that a company cannot trade, and we record them rather than treating them as a verdict.
Partner link. We earn a commission if you start care through it, at no extra cost to you. Who pays us.
Every company we have reviewed is on the reviews index, and the reviews are written by Kevin Turner.